Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Atea Pharmaceuticals, Inc.

NASDAQ: AVIR · Life Sciences · 3 alerts · CIK 1593899

Share price
$4.12Close, Nov 16
Market cap
$331M
Shares outstanding
80.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Atea Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:30 AM ET 8-K
Loan & Debt

Atea Pharmaceuticals $200M Debt Financing with Hercules Capital, Inc.

Atea Pharmaceuticals entered into a $200 million senior secured term loan facility with Hercules Capital, with an initial $65 million drawn at closing. Additional tranches are available upon achieving clinical and commercial milestones related to the bemnifosbuvir and ruzasvir (BEM/RZR) program. The facility matures in November 2031 and carries a floating interest rate starting at a minimum of 9.35%.

Value
$200M
Counterparty
Hercules Capital, Inc.
Term
through Nov 2031

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.